Jennifer K. Moses
2020
In 2020, Jennifer K. Moses earned a total compensation of $1.7M as Chief Financial Officer at G1 Therapeutics, a 18% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $141,050 |
---|---|
Option Awards | $1,116,239 |
Salary | $398,583 |
Other | $8,550 |
Total | $1,664,422 |
Moses received $1.1M in option awards, accounting for 67% of the total pay in 2020.
Moses also received $141.1K in non-equity incentive plan, $398.6K in salary and $8.6K in other compensation.
Rankings
In 2020, Jennifer K. Moses' compensation ranked 6,371st out of 13,090 executives tracked by ExecPay. In other words, Moses earned more than 51.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,371 | 51st |
Manufacturing | 2,627 | 53rd |
Chemicals And Allied Products | 1,059 | 53rd |
Drugs | 915 | 53rd |
Pharmaceutical Preparations | 683 | 53rd |
Moses' colleagues
We found five more compensation records of executives who worked with Jennifer K. Moses at G1 Therapeutics in 2020.